Patents by Inventor Christopher S. Dodds

Christopher S. Dodds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20010003863
    Abstract: The present invention pertains to methods of preparing prismatic cells which comprise the steps of winding lithium metal anode, separator, and cathode layers on a rounded mandrel having a large circumference relative to the external dimensions of the prismatic cell stack and of compressing the multilayer rounded cell stack into a prismatic shape and then filling the prismatic subassembly with electrolyte to form a prismatic ell stack, or alternatively of winding into such a rounded cell stack and filling with electrolyte and then compressing into a prismatic cell stack, prior to enclosing the prismatic cell stack in a barrier material film and sealing to form the casing of the prismatic cell. The present invention also pertains to electric current producing cells prepared according to such methods.
    Type: Application
    Filed: January 25, 2001
    Publication date: June 21, 2001
    Inventors: William C. Thibault, Eric V. Kanto, Yordan M. Gernov, Christopher S. Dodds, Terje A. Skotheim
  • Patent number: 6190426
    Abstract: The present invention pertains to methods of preparing prismatic cells which comprise the steps of winding lithium metal anode, separator, and cathode layers on a rounded mandrel having a large circumference relative to the external dimensions of the prismatic cell stack and of compressing the multilayer rounded cell stack into a prismatic shape and then filling the prismatic subassembly with electrolyte to form a prismatic ell stack, or alternatively of winding into such a rounded cell stack and filling with electrolyte and then compressing into a prismatic cell stack, prior to enclosing the prismatic cell stack in a barrier material film and sealing to form the casing of the prismatic cell. The present invention also pertains to electric current producing cells prepared according to such methods.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: February 20, 2001
    Assignee: Moltech Corporation
    Inventors: William C. Thibault, Eric V. Kanto, Yordan M. Gernov, Christopher S. Dodds, Terje A. Skotheim
  • Patent number: RE49880
    Abstract: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: March 26, 2024
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Alaric J. Dyckman, Dharmpal S. Dodd, John E. Macor, Christopher P. Mussari, Laxman Pasunoori, Sreekantha Ratna Kumar, Trevor C. Sherwood, Ramesh Kumar Sistla
  • Patent number: RE49893
    Abstract: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: April 2, 2024
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Alaric J. Dyckman, Dharmpal S. Dodd, Tasir Shamsul Hague, Louis J. Lombardo, John E. Macor, Christopher P. Mussari, Laxman Pasunoori, Sreekantha Ratna Kumar, Trevor C. Sherwood, Shoshana L. Posy, Ramesh Kumar Sistla, Subramanya Hegde, Anupama Kandhi Ramachandra Reddy
  • Patent number: RE49931
    Abstract: Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: April 23, 2024
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alaric J. Dyckman, Dharmpal S. Dodd, Christopher P. Mussari, Laxman Pasunoori, Sreekantha Ratna Kumar